| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.53 | 0.0003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |